The robustness of this pathway is normally well-controlled by NLR stringency; however, “hair-trigger” activation of caspase-1 drives inflammation during atherosclerosis, diabetes, Alzheimer's, inflammatory bowel disease, cancer, and several auto-inflammatory genetic disorders. Here, CASP1 is linked to cancer.